[Dysthymic disorders and dopaminergic drugs].
Schmitt
L
L
Service Universitaire de Psychiatrie et de Psychologie Médicale, Hôpital Casselardit, Toulouse.
Olivier
F
F
Fournié-DeJean
I
I
D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D004298:Dopamine / Q000502:physiology; D015259:Dopamine Agents / Q000627:therapeutic use*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology
D015259:Dopamine Agents; D008996:Monoamine Oxidase Inhibitors; D011954:Receptors, Dopamine; D004298:Dopamine
Dysthymies et médicaments dopaminergiques.